Home LiteratureArticle Details
PMID: 31274626 Published · ppublish English

Diverse Behavior in 18F-Fluorocholine PET/CT of Brain Tumors in Patients With Neurofibromatosis Type 1.

Clinical nuclear medicine ·Vol. 44 ·No. 8 ·2019-08-00

Pena Pardo FJ, Moreno JMB, Jiménez Aragón F, González García J, García Vicente AM

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder that causes CNS tumors in around 20% of patients, being pilocytic astrocytomas (PA), and particularly optic pathway gliomas (OPG), the most common. We present three cases of NF1 patients referred for F-fluorocholine PET/CT because of suspected glioma in the setting of ongoing FUMEGA (Functional and Metabolic Glioma Analysis) trial. One case turned out to be a WHO grade I ganglioglioma; the second was a high grade glioma; and the last one (negative in PET) a probable low-grade glioma.

MeSH 主题词
Adult Brain Neoplasms/diagnostic imaging,pathology Choline/analogs & derivatives Humans Male Neoplasm Grading Neurofibromatosis 1/diagnostic imaging,pathology Positron Emission Tomography Computed Tomography
Article Info
Journal
Clinical nuclear medicine
Abbr.
Clin Nucl Med
ISSN
1536-0229
Published
2019-08-00
Language
English
Country/Region
United States
NLM ID
7611109
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com